A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration

Experimental Neurology

Volumn 147, Issue 2, 1997, Pages 269-278

  Gold, Bruce G ^a   Zeleny Pooley, Michelle ^a   Wang, Min Sheng ^a   Chaturvedi, Pravin ^b   Armistead, David M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOPHILIN; CYCLOSPORIN A; TACROLIMUS;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; NERVE FIBER GROWTH; NERVE REGENERATION; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCIATIC NERVE; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0031258791     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6630     Document Type: Article

References (26)

1. Armistead D. M., Badia M. C., Deininger D. D., Duffy J. P., Saunders J. O., Tung R. D., Thomson J. A., Decenzo M. T., Futer O., Livingston D. J., Murcko M. A., Yamashita M. M., Navia M. A. Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallogr. 51:1995;522-528.
2. Cardenas M. E., Zhu D., Heitman J. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr. Opin. Nephrol. Hypertens. 4:1995;472-477.
3. Forman D. S., Berenberg R. A. Regeneration of motor axons in the rat sciatic nerve studied by labeling with axonally transported radioactive proteins. Brain Res. 156:1978;213-225.
4. Friedman J., Weissman I. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA. Cell. 66:1991;799-806.
5. Gold B. G., Katoh K., Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15:1995;7505-7516.
6. Gold B. G., Storm-Dickerson T., Austin D. R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6:1994;287-296.
7. Gold B. G., Wang M. S., Zeleny-Pooley M. FK506 and cyclosporin A: Comparative dose-dependency studies on the rate of axonal regeneration in the rat sciatic nerve. Soc. Neurosci. Abstr. 22:1996;264.
8. Gold B. G., Zeleny-Pooley M., Wang M.-S., Chaturvedi P., Armistead D. M., McCaffrey P. G. FKBP ligands speed functional recovery and nerve regeneration in the rat sciatic nerve following oral administration. Soc. Neurosci. Abstr. 1997.
9. Harding M. W., Galat A., Uehling D. E., Schreiber S. L. A receptor for the immunosuppressant FK506 is acis-trans. Nature. 341:1989;758-760.
10. Jacob J. M., McQuarrie I. G. Acceleration of axonal outgrowth in rat sciatic nerve at one week after axotomy. J. Neurobiol. 24:1993;356-367.
11. Kanje M., Lundborg G., Edström A. A new method for studies of the effects of locally applied drugs on peripheral nerve regenerationin vivo. Brain Res. 439:1988;116-121.
12. Liu J., Albers M. W., Wandless T. J., Luan S., Alberg D. G., Belshaw P. J., Cohen P., Mackintosh C., Klee C. B., Schreiber S. L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineruin phosphatase activity. Biochemistry. 31:1992;3896-3901.
13. Liu J., Farmer J. D., Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
14. Mcquarrie I. G., Grafstein B., Gershorn M. B. Axonal regeneration in the rat sciatic nerve: Effects of a conditioning lesion and dbc-AMP. Brain Res. 132:1977;443-453.
15. 1. J. Immunol. 150:1993;2139-2147.
16. Ramon y Cajal S. Degeneration and Regeneration of the Nervous System. 1928;Oxford Univ. Press, London.
17. Siekierka J. J., Hung S. H. Y., Poe M., Lin C. S., Sigal N. H. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 341:1989;755-757.
18. Sigal N. H., Dumont F. J. Cyclosporin A, FK-506, and Rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:1992;519-560.
19. Snyder S. H., Sabatini D. M. Immunophilins and the nervous system. Nature Med. 1:1995;32-37.
20. Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., Snyder S. H. Neurotrophic actions of nonimmunosuppressive ligands of immunophilins. Nature Med. 3:1997;1-8.
21. Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A. C., Suzdak P. D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997;2019-2024.
22. Walker J. L., Resig P., Guarnieri S., Sisken B. F., Evans J. M. Improved footprint analysis using video recording to assess functional recovery following injury to the rat sciatic nerve. Restor. Neurol. Neurosci. 6:1994;189-193.
23. Wang M. S., Zeleny-Pooley M., Gold B. G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in rat sciatic nerve. J. Pharmacol. Exp. Ther. 282:1997;1084-1093.
24. Wiederrecht G., Etzkorn F. The immunophilins. Perspect. Drug Discovery Design. 2:1994;57-84.
25. Wiederrecht G., Lam E., Hung S., Martin M., Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann. NY Acad. Sci. 696:1993;9-19.
26. Wujek J. R., Lasek R. J. Correlation of axonal regeneration and slow component B in two branches of a single axon. J. Neurosci. 3:1983;243-251.